1. Home
  2. DOMO vs VNDA Comparison

DOMO vs VNDA Comparison

Compare DOMO & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DOMO
  • VNDA
  • Stock Information
  • Founded
  • DOMO 2010
  • VNDA 2002
  • Country
  • DOMO United States
  • VNDA United States
  • Employees
  • DOMO N/A
  • VNDA N/A
  • Industry
  • DOMO Computer Software: Prepackaged Software
  • VNDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • DOMO Technology
  • VNDA Health Care
  • Exchange
  • DOMO Nasdaq
  • VNDA Nasdaq
  • Market Cap
  • DOMO 559.7M
  • VNDA 261.7M
  • IPO Year
  • DOMO 2018
  • VNDA 2006
  • Fundamental
  • Price
  • DOMO $14.82
  • VNDA $5.02
  • Analyst Decision
  • DOMO Hold
  • VNDA Strong Buy
  • Analyst Count
  • DOMO 6
  • VNDA 3
  • Target Price
  • DOMO $12.17
  • VNDA $15.33
  • AVG Volume (30 Days)
  • DOMO 688.9K
  • VNDA 414.8K
  • Earning Date
  • DOMO 08-28-2025
  • VNDA 07-30-2025
  • Dividend Yield
  • DOMO N/A
  • VNDA N/A
  • EPS Growth
  • DOMO N/A
  • VNDA N/A
  • EPS
  • DOMO N/A
  • VNDA N/A
  • Revenue
  • DOMO $317,052,000.00
  • VNDA $201,351,000.00
  • Revenue This Year
  • DOMO $1.71
  • VNDA $16.86
  • Revenue Next Year
  • DOMO $2.43
  • VNDA $39.78
  • P/E Ratio
  • DOMO N/A
  • VNDA N/A
  • Revenue Growth
  • DOMO N/A
  • VNDA 13.37
  • 52 Week Low
  • DOMO $6.01
  • VNDA $3.81
  • 52 Week High
  • DOMO $15.09
  • VNDA $6.37
  • Technical
  • Relative Strength Index (RSI)
  • DOMO 67.51
  • VNDA 67.29
  • Support Level
  • DOMO $13.54
  • VNDA $4.66
  • Resistance Level
  • DOMO $14.82
  • VNDA $4.95
  • Average True Range (ATR)
  • DOMO 0.73
  • VNDA 0.15
  • MACD
  • DOMO -0.01
  • VNDA 0.03
  • Stochastic Oscillator
  • DOMO 94.04
  • VNDA 89.39

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: